Multi-Omics Profiling in PGM3 and STAT3 Deficiencies: A Tale of Two Patients

Multi-Omics Profiling in PGM3 and STAT3 Deficiencies: A Tale of Two Patients

Hyper-IgE Syndrome (HIES) is a heterogeneous group of primary immune-deficiency disorders characterized by elevated levels of IgE, eczema, and recurrent skin and lung infections. HIES that is autosomally dominant in the signal transducer and activator of transcription 3 (STAT3), and autosomal recess...

Full description

Bibliographic Details
Main Authors:	Minnie Jacob, Afshan Masood, Anas M. Abdel Rahman
Format:	Article
Language:	English
Published:	MDPI AG 2023-01-01
Series:	International Journal of Molecular Sciences
Subjects:	signal transducer and activator of transcription 3 (STAT3) phosphoglucomutase 3 (PGM3) dedicator of cytokinesis 8 (DOCK8) hyper IgE syndromes (HIES) multi-omics metabolomics
Online Access:	https://www.mdpi.com/1422-0067/24/3/2406

Similar Items

Hyper-IgE syndrome. Lessons from function and defects of STAT-3 or DOCK-8
by: Julio César Alcántara-Montiel, et al.
Published: (2016-10-01)

Dominant-negative signal transducer and activator of transcription (STAT)3 variants in adult patients: A single center experience
by: Oded Shamriz, et al.
Published: (2022-12-01)

In Vitro Skeletal Muscle Model of PGM1 Deficiency Reveals Altered Energy Homeostasis
by: Federica Conte, et al.
Published: (2023-05-01)

REC8 regulates neuroblastoma cell proliferation, migration, invasion, and angiogenesis via STAT3/VEGF signaling
by: Qiang Wang, et al.
Published: (2023-12-01)

Astragalus polysaccharide ameliorates CD8+ T cell dysfunction through STAT3/Gal-3/LAG3 pathway in inflammation‐induced colorectal cancer
by: Qiuyi Li, et al.
Published: (2024-02-01)

Identification, Characteristics and Function of Phosphoglucomutase (PGM) in the Agar Biosynthesis and Carbon Flux in the Agarophyte <i>Gracilariopsis lemaneiformis</i> (Rhodophyta)
by: Qionglin Chen, et al.
Published: (2022-07-01)

YAP/STAT3 inhibited CD8+ T cells activity in the breast cancer immune microenvironment by inducing M2 polarization of tumor‐associated macrophages
by: Chen Wang, et al.
Published: (2023-08-01)

Deciphering the role of DOCK8 in tumorigenesis by regulating immunity and the application of nanotechnology in DOCK8 deficiency therapy
by: Longhui Zhang, et al.
Published: (2022-11-01)

Interventional pulmonary procedures and their outcomes in patients with STAT3 hyper IgE syndrome
by: Seyed Alireza Mahdaviani, et al.
Published: (2023-09-01)

MARCH8 Suppresses Tumor Metastasis and Mediates Degradation of STAT3 and CD44 in Breast Cancer Cells
by: Wenjing Chen, et al.
Published: (2021-05-01)

Construction and characterization of mice with conditional knockout of Stat3 gene in microglia
by: ZHU Xiaochen, et al.
Published: (2023-06-01)

Chemoreversal Agents from Taiwanofungus Genus and Their More Potent Methyl Derivatives Targeting Signal Transducer and Activator of Transcription 3 (STAT3) Phosphorylation
by: Ko-Hua Yu, et al.
Published: (2021-09-01)

Novel PGM3 mutation in two siblings with combined immunodeficiency and childhood bullous pemphigoid: a case report and review of the literature
by: Mazdak Fallahi, et al.
Published: (2022-12-01)

Expression of STAT3 in endometrial carcinoma and its clinicopathological significance
by: SUN Xinzhao, LUO Yanlu, FAN Jiangtao, ZHONG Xueyan
Published: (2023-10-01)

STAT3 inhibition decreases ATP-induced gene expression in human airway epithelial cells
by: Cheol Hong Kim, et al.
Published: (2022-06-01)

STAT3, the Challenge for Chemotherapeutic and Radiotherapeutic Efficacy
by: Ping-Lian Yang, et al.
Published: (2020-08-01)

The Role of STAT3 Signaling Pathway Activation in Subconjunctival Scar Formation after Glaucoma Filtration Surgery
by: Yanxia Li, et al.
Published: (2023-07-01)

Adiponectin Deficiency Enhances Anti-Tumor Immunity of CD8+ T Cells in Rhabdomyosarcoma Through Inhibiting STAT3 Activation
by: Jiao Peng, et al.
Published: (2022-04-01)

Influence of H2O2 and O3 on PGM Extraction from Used Car Catalysts
by: A. Fornalczyk, et al.
Published: (2018-06-01)

A STAT3 of Addiction: Adipose Tissue, Adipocytokine Signalling and STAT3 as Mediators of Metabolic Remodelling in the Tumour Microenvironment
by: Rose Kadye, et al.
Published: (2020-04-01)

The impact of STAT3 and phospho-STAT3 expression on the prognosis and clinicopathology of ovarian cancer: a systematic review and meta-analysis
by: Shuo Gao, et al.
Published: (2021-11-01)

The research development of STAT3 in hepatic ischemia-reperfusion injury
by: Hanwen Yang, et al.
Published: (2023-01-01)

STAT3 pathway in cancers: Past, present, and future
by: Han‐Qi Wang, et al.
Published: (2022-06-01)

Association of hyper IgE with herpetic viral encephalitis and ecthyma gangrenosum in a male Egyptian patient
by: Hamdi Ibrahim, et al.
Published: (2023-01-01)

Transcription Factor STAT3 as a Novel Molecular Target for Cancer Prevention
by: Ailian Xiong, et al.
Published: (2014-04-01)

STAT3 and p63 in the Regulation of Cancer Stemness
by: Shixiong Wei, et al.
Published: (2022-08-01)

STAT3 in Cancer—Friend or Foe?
by: Hai-Feng Zhang, et al.
Published: (2014-07-01)

Biological Hallmarks and Emerging Strategies to Target STAT3 Signaling in Multiple Myeloma
by: Jianbiao Zhou, et al.
Published: (2022-03-01)

STAT3 Activation in Glioblastoma: Biochemical and Therapeutic Implications
by: Jennifer E. Kim, et al.
Published: (2014-02-01)

MPP8 Governs the Activity of the LIF/STAT3 Pathway and Plays a Crucial Role in the Differentiation of Mouse Embryonic Stem Cells
by: Heyao Zhang, et al.
Published: (2023-08-01)

Neobaicalein Inhibits Th17 Cell Differentiation Resulting in Recovery of Th17/Treg Ratio through Blocking STAT3 Signaling Activation
by: Jian-Yu Chen, et al.
Published: (2022-12-01)

STAT3 Expression and Correlation Between Ki-67 and PHH3 in Meningiomas: Is it Possible to Predict Recurrence?
by: Sinem Kantarcıoğlu Coşkun, et al.
Published: (2022-08-01)

Milk fat globule EGF factor 8 restores mitochondrial function via integrin‐medicated activation of the FAK‐STAT3 signaling pathway in acute pancreatitis
by: Yifan Ren, et al.
Published: (2021-02-01)

STAT3 Activation in Psoriasis and Cancers
by: Megumi Kishimoto, et al.
Published: (2021-10-01)

STAT3 Dysregulation in Mature T and NK Cell Lymphomas
by: Angelina Seffens, et al.
Published: (2019-11-01)

Long term longitudinal follow-up of an AD-HIES cohort: the impact of early diagnosis and enrollment to IPINet centers on the natural history of Job’s syndrome
by: Maria Carrabba, et al.
Published: (2023-04-01)

Redox Regulation of STAT1 and STAT3 Signaling
by: Elena Butturini, et al.
Published: (2020-09-01)

Structural Implications of STAT3 and STAT5 SH2 Domain Mutations
by: Elvin D. de Araujo, et al.
Published: (2019-11-01)

Exploring Novel Frontiers: Leveraging STAT3 Signaling for Advanced Cancer Therapeutics
by: Taiwo Adesoye, et al.
Published: (2024-01-01)

Hematopoietic stem cell transplantation in patient with DOCK8 deficiency: Ukrainian experience
by: A.M. Hilfanova, et al.
Published: (2023-09-01)